S
Senthamaraikannan Kabilan
Researcher at Annamalai University
Publications - 145
Citations - 2025
Senthamaraikannan Kabilan is an academic researcher from Annamalai University. The author has contributed to research in topics: Antibacterial activity & Antimicrobial. The author has an hindex of 22, co-authored 141 publications receiving 1624 citations. Previous affiliations of Senthamaraikannan Kabilan include Instituto Superior de Engenharia de Lisboa.
Papers
More filters
Journal ArticleDOI
Design, synthesis, characterization, molecular docking and computational studies of 3-phenyl-2-thioxoimidazolidin-4-one derivatives
TL;DR: In vitro and in vivo anticancer activities of these compounds will be evaluated in future.
Journal ArticleDOI
Synthesis, stereochemistry and antimicrobial studies of novel oxime ethers of aza/diazabicycles
Paramasivam Parthiban,Gopalakrishnan Aridoss,Gopalakrishnan Aridoss,Paramasivam Rathika,Venkatachalam Ramkumar,Senthamaraikannan Kabilan +5 more
TL;DR: Most of the molecules expressed promising antimicrobial profile against the tested pathogens and even a few compounds 16, 21, 22, 33 and 34 were better than standard drugs.
Journal ArticleDOI
β-Iminoenamine-BF2 complexes: aggregation-induced emission and pronounced effects of aliphatic rings on radiationless deactivation.
Karthikeyan Perumal,Jai Anand Garg,Olivier Blacque,Ramanathan Saiganesh,Senthamaraikannan Kabilan,Kallupattu Kuppusamy Balasubramanian,Koushik Venkatesan +6 more
TL;DR: For most of the studied compounds, time-dependent DFT (TD-DFT) calculations invariably reveal intramolecular charge transfer (π-π*) characteristics with the frontier orbitals concentrated on the boron-nitrogen heterocycle.
Journal ArticleDOI
Synthesis and biological evaluation of novel benzimidazol/benzoxazolylethoxypiperidone oximes.
Srinivasan Balasubramanian,Gopalakrishnan Aridoss,Paramasivam Parthiban,C. Ramalingan,Senthamaraikannan Kabilan +4 more
TL;DR: Some novel benzimidazol/benzoxazolylethoxypiperidone oximes synthesized exerted potent in vitro antibacterial activity against Bacillus subtilis, Escherichia coli and Staphylococcus aureus while compounds 26, 29 and 30 exhibited powerful in vitro antifungal activity against Candida albicans, Candida-51, and Aspergillus niger.
Journal ArticleDOI
Synthesis, stereochemistry and antimicrobial evaluation of some N-morpholinoacetyl-2,6-diarylpiperidin-4-ones
TL;DR: Structural-activity relationship results for these nine compounds have shown that compounds 26 and 27 exerted excellent antibacterial activity against all the bacterial strains used except 27 against S. aureus.